References
- Petricoin, E F.; Ardekani, A M.; Hitt, B A.; Levine, P J.; Fusaro, V A.; , et al. Use of proteomic patterns in serum to identify ovarian cancer.Lancet 2002, 359, 572–577. [PUBMED], [INFOTRIEVE], [CSA]
- Tyers, M.; Mann, M. From genomics to proteomics.Nature 2003, 422, 193–197. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Graves, P R.; Haystead, T A. Molecular biologist's guide to proteomics.Microbiol. Mol. Biol. Rev. 2002, 66, 39–63. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Fung, E T. Strategies in clinical proteomics: from discovery to assay.Preclinica 2004, 2, 253–258. [CSA]
- Hanash, S. Disease proteomics.Nature 2003, 422, 226–232. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jain, K K. Recent advances in oncoproteomics.Curr. Opin. Mol. Ther. 2002, 4, 203–209. [PUBMED], [INFOTRIEVE], [CSA]
- Wittke, S.; Kaiser, T.; Mischak, H. Differential polypeptide display: the search for the elusive target.J. Chromatogr., B, Anal. Technol. Biomed. Life. Sci. 2004, 803, 17–26. [CSA]
- Bischoff, R.; Luider, T M. Methodological advances in the discovery of protein and peptide disease markers.J. Chromatogr., B, Anal. Technol. Biomed. Life. Sci. 2004, 803, 27–40. [CSA]
- Aebersold, R. A mass spectrometric journey into protein and proteome research.J. Am. Soc. Mass Spectrom. 2003, 14, 685–695. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Aebersold, R.; Mann, M. Mass spectrometry-based proteomics.Nature 2004, 422, 198–207. [CSA], [CROSSREF]
- Lahm, H W.; Langen, H. Mass spectrometry: a tool for the identification of proteins separated by gels.Electrophoresis 2000, 21, 2105–2114. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pandey, A.; Andersen, J S.; Mann, M. Use of mass spectrometry to study signaling pathways.Sciences's STKE 2000, 32, 1–12. [CSA]
- Werner, T. Proteomics and regulomics: the yin and yang of functional genomics.Mass Spectrom. Rev. 2004, 23, 25–33. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pusch, W.; Floccoo, M T.; Leung, S.; Thiele, H.; Kostrzewa, M. Mass spectrometry-based clinical proteomics.Pharmacogenomics 2003, 4, 463–476. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Corthals, G L.; Wasinger, V C.; Hochstrasser, D F.; Sanchez, J C. The dynamic range of protein expression: a challenge for proteomic research.Electrophoresis 2000, 21, 1104–1115. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Roboz, J. Mass Spectrometry in Cancer Research; CRC Press: Boca Raton, FL, 2002.
- Weinberger, S R.; Dalmasso, E A; Fung, E T. Current achievements using ProteinChip Array Technology.Curr. Opin. Chem. Biol. 2001, 6, 86–91. [CSA], [CROSSREF]
- Merchant, M.; Weinberger, S R. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry.Electrophoresis 2002, 21, 1164–1177. [CSA], [CROSSREF]
- Merchant, M.; Weinberger, S R. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry.Electrophoresis 2000, 21, 1164–1174. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Merchant, M.; Rubin, R B. A rapid protein profiling system that speeds study of cancer and other diseases.Am. Clin. Lab. 2000, 19, 28–29. [PUBMED], [INFOTRIEVE], [CSA]
- Tang, N.; Tornatore, P.; Weinberg, S R. Current developments in SELDI affnity technology.Mass Spectrom. Rev. 2004, 23, 34–44. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wiesner, A. Detection of tumor markers with ProteinChip technology.Curr. Pharm. Biotechnol. 2004, 5, 45–67. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Craven, R A.; Banks, R E. Laser capture microdissection and proteomics: possibilities and limitation.Proteomics 2001, 1, 1200–1204. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kwapiszewska, G.; Meyer, M.; Bogumil, R.; Bohle, R M.; Seeger, W.; Weissmann, N.; Fink, L. Identification of proteins in laser-microdissected small cell numbers by SELDI-TOF and tandem MS.BMC Biotechnol. 2004, 4, 30–32. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Caputo, E.; Moharram, R.; Martin, B M. Methods for on-chip protein analysis.Anal. Biochem. 2003, 321, 116–124. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lin, S.; Tornatore, P.; King, D.; Orlando, R.; Weinberger, S R. Limited acid hydrolysis as a means of fragmenting proteins isolated upon proteinchip array surfaces.Proteomics 2001, 1, 1172–1184. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kelleher, N L. From primary structure to function: biological insights from large-molecule mass spectra.Chem. Biol. 2000, 7, R37–R45. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Aebersold, R.; Goodlett, D R. Mass spectrometry in proteomics.Chem. Rev. 2001, 101, 269–295. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Persson, B. Bioinformatics in protein analysis.EXS 2000, 88, 215–231. [PUBMED], [INFOTRIEVE], [CSA]
- Boguski, M S.; McIntosh, M W. Biomedical informatics for proteomics.Nature 2003, 42, 233–237. [CSA], [CROSSREF]
- Li, L.; Tang, H.; Wu, Z.; Gong, J.; Gruidl, M.; , et al. Data mining techniques for cancer detection using serum proteomic profiling.Artif. Intell. Med. 2004, 32, 71–83. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Fenyo, D. Identifying the proteome: software tools.Curr. Opin. Biotechnol. 2000, 11, 391–395. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cannon, J S.; Gilbert, K.; Wang, Z.; Yip, C. From biomarker discovery to assay using SELDI TOF-MS technology.Am. Biotechnol. Lab. 2004 November 18–19. [CSA]
- Mortz, E.; O'Connor, P B.; Roepstorff, P.; Kelleher, N L.; Wood, T D.; McLafferty, F W.; Mann, M. Sequence tag identification of intact proteins by matching tanden mass spectral data against sequence data bases.Proc. Natl. Acad. Sci. U. S. A. 1996, 93, 8264–8267. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Griffin, P R.; MacCoss, M J.; Eng, J K.; Blevins, R A.; Aaronson, J S.; Yates, J R. Direct database searching with MALDI-PSD spectra of peptides.Rapid Commun. Mass Spectrom. 1995, 9, 1546–1551. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Loo, J A.; Brown, J.; Critchley, G.; Mitchell, C.; Andrews, P C.; Ogorzalek Loo, R R. High sensitivity mass spectrometric methods for obtaining intact molecular weights from gel-separated proteins.Electrophoresis 1999, 20, 743–748. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Oda, Y.; Huang, K.; Cross, F R.; Cowburn, D.; Chait, B T. Accurate quantification of protein expression and site-specific phosphorylation.Proc. Natl. Acad. Sci. U. S. A. 1999, 96, 6591–6596. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Fung, E T.; Enderwick, C. ProteinChip@ clinical proteomics: computational challenges and solutions.BioTechniques 2002, 32 Suppl., S34–S41. [CSA]
- Qu, Y.; Adam, B.; Yasui, Y.; Ward, M.; Cazares, H.; , et al. Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients.Clin. Chem. 2002, 48, 1835–1843. [PUBMED], [INFOTRIEVE], [CSA]
- Adam, B L.; Qu, Y S.; Davis, J W.; Ward, M D.; Clements, M A.; , et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.Cancer Res. 2002, 62, 3609–3614. [PUBMED], [INFOTRIEVE], [CSA]
- Wagber, M.; Naik, D N.; Pothen, A.; Kasakurti, S.; , et al. Computational protein biomarker prediction: a case study for prostate cancer.BMC Bioinformatics 2004, 5, 26–28. [CSA], [CROSSREF]
- Li, J.; Zhang, Z.; Rosenzweig, J.; Wang, Y Y.; Chan, D W. Proteomics and bioinformatics approach for identification of serum biomarkers to detect breast cancer.Clin. Chem. 2002, 48, 1296–1304. [PUBMED], [INFOTRIEVE], [CSA]
- Koopmann, J.; Zhang, Z.; White, N.; Rosenzweig, J.; Fedarko, N.; , et al. Serum diagnosis of pancreatic adenocarcinoma using surface-ehanced laser desorption and ionization mass spectrometry.Clin. Cancer Res. 2004, 10, 860–868. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ball, G.; Mian, S.; Holding, F.; Allibone, R O.; Lowe, J.; , et al. An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers.Bioinformatics 2002, 18, 395–404. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Li, L.; Umbach, D M.; Terry, P.; Taylor, J A. Application of the GA/KNN method to SELDI proteomics data.Bioinformatics 2004, 20, 1638–1640. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zhu, W.; Wang, X.; Ma, Y.; Rao, M.; Glimm, J.; Kovach, J S. Detection of cancer-specific markers amid massive mass spectral data.Proc. Natl. Acad. Sci. U. S. A. 2003, 100, 14666–14671. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lilien, R H.; Farid, H.; Donald, B R. Probabilistic disease classification of expression-dependent proteomic data from mass spectrometry of human serum.J. Comput. Biol. 2003, 10, 925–946. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bandera, C A.; Ye, B.; Mok, S C. New technologies for the identification of markers for early detection of ovarian cancer.Curr. Opin. Obstet. Gynecol. 2003, 15, 51–55. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jones, M B.; Krutzsch, H.; Shu, H.; Zhao, Y.; Liotta, L A.; Kohn, E C.; Petricoin, E F.I. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer.Proteomics 2002, 2, 76–84. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ardekani, A M.; Liotta, L A.; Petricoin, E F. Clinical potential of proteomics in the diagnosis of ovarian cancer.Expert Rev. Mol. Diagn. 2002, 2, 312–320. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sorace, J M.; Zhan, M. A data review and re-assesment of ovarian cancer serum proteomic profiling.BMC Bioinformatics 2003, 4, 24. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Alexe, G.; Alexe, S.; Liotta, L A.; Petricoin, E F.; Reiss, M.; Hammer, P L. Ovarian cancer detection by logical analysis of proteomic data.Proteomics 2004, 4, 766–783. [PUBMED], [INFOTRIEVE], [CSA]
- Rai, A J.; Zhang, Z.; Rosenzweig, J.; Shih, L.; Pham, T.; , et al. Proteomic approaches to tumor marker discovery.Arch. Pathol. Lab. Med. 2002, 126, 1518–1526. [PUBMED], [INFOTRIEVE], [CSA]
- Kozak, K R.; Amneus, M W.; Pusey, S M.; Su, F.; , et al. Identification of biomarkers for ovarian cancer using strong anion-exchange proteinchips: potential use in diagnosis and prognosis.Proc. Natl. Acad. Sci. 2003, 100, 12343–12348. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ye, B.; Cramer, W.; Skates, S J.; Horick, N K.; , et al. Haptoglobin subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry.Clin. Cancer Res. 2003, 9, 2904–2911. [PUBMED], [INFOTRIEVE], [CSA]
- Zhang, Z.; Bast, R C.; Yu, Y.; Li, J.; , et al. Thee biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer.Cancer Res. 2004, 64, 5882–5890. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Conrads, T P.; Fusaro, V A.; Ross, S.; Johann, D.; Rajapakse, V.; , et al. High-resolution serum proteomic features for ovarian cancer detection.Endocr.-Relat. Cancer 2004, 11, 163–178. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Yang, E C.; Guo, J.; Diehl, G.; DeSouza, L.; Rodrigues, M J.; , et al. Protein expression profiling of endometrial malignanices reveals a new tumor marker: chaperonin 10.J. Proteome Res. 2004, 3, 636–642. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Liotta, L.; Petricoin, E F. Molecular profiling of human cancer.Nat. Rev., Genet. 2000, 1, 48–56. [CSA], [CROSSREF]
- Pusztai, L.; Gregory, B W.; Baggerly, K A.; Peng, B.; Koomen, J.; , et al. Pharmacoproteomic analysis of prechemotherapy and postchemotherpy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma.Cancer 2004, 100, 1814–1822. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Paweletz, C P.; Trock, B.; Pennanen, M.; Tsangaris, T.; Magnant, C.; Liotta, L A.; Petricoin, E F., III. Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer.Dis. Markers 2001, 17 (4), 301–307 and 2002, 17, 301–307. [PUBMED], [INFOTRIEVE], [CSA]
- Sauter, E R.; Zhu, W.; Wassell, R P.; Chervoneva, I.; Du Bois, G C. Proteomic analysis of nipple aspirate fluid to detect biologic markers of breast cancer.Br. J. Cancer 2002, 86, 1440–1443. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Coombes, K R.; Fritsche, H A.; Clarke, C.; Chen, J.; Baggerly, K A.; , et al. Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surface-enhanced laser desorption and ionization.Clin. Chem. 2003, 49, 1615–1623. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wright, G L.; Cazares, L H.; Leung, S.; Nasim, S.; Adam, B.; , et al. Proteinchip surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel biochip technology for detection of prostate cancer biomarkers in complex protein mixtures.Prostate Cancer Prostatic Dis. 1999, 2, 264–276. [CSA], [CROSSREF]
- Cazares, L H.; Adam, B.; Ward, M D.; Nasim, S.; , et al. Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry.Clin. Cancer Res. 2002, 8, 2541–2552. [PUBMED], [INFOTRIEVE], [CSA]
- Semmes, O J.; Feng, Z.; Adam, B L.; Banez, L L.; Bigbee, W L.; , et al. Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: 1. assessment of platform reproducibility.Clin. Chem. 2005, 51, 102–112. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Petricoin, E F.; Ornstein, K.; Paweletz, C P.; Ardekani, A.; , et al. Serum proteomic patterns for detection of prostate cancer.J. Natl. Cancer Inst. 2003, 95, 489–490. [CSA]
- Tong, W.; Xie, Q.; Hong, H.; Shi, L.; Fang, H.; Perkins, R.; Petricoin, E F. Using decision forest to classify prostate cancer samples on the basis of SELDI-TOF MS data: assessing chance correlation and prediction confidence.Environ. Health Perspect. 2004, 112, 1622–1627. [PUBMED], [INFOTRIEVE], [CSA]
- Bañez, L.; Prasanna, P.; Sun, L.; Ali, A.; Zou, Z.; , et al. Diagnostic potential of serum proteomic patterns in prostate cancer.J. Urol. 2003, 170, 442–446. [CSA]
- Lehrer, S.; Roboz, J.; Ding, H.; Zhao, S.; Diamond, E J.; , et al. Putative protein markers in the sera of men with prostatic neoplasms.Br. J. Urol. Int. 2003, 92, 223–225. [CSA]
- Hlavaty, J J.; Partin, A W.; Kusinitz, F.; Shue, M J.; Stieg, A.; Bennett, K.; Briggman, J V. Mass spectrometry as a discovery tool for identifying serum markers for prostate cancer.Clin. Chem. 2001, 47, 1924–1926. [CSA]
- Hlavaty, J J.; Partin, A W.; Shue, M J.; Mangold, L A.; Derby, J.; , et al. Identification and preliminary clinical evaluation of a 50.8-kDa serum marker for prostate cancer.Urology 2003, 61, 1261–1265. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Vlahou, A.; Schellhammer, P F.; Mendrinos, S.; Patel, K.; Kondylis, F I.; , et al. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine.Am. J. Pathol. 2001, 158, 1491–1502. [PUBMED], [INFOTRIEVE], [CSA]
- Zhang, Y F.; Wu, D L.; Guan, M.; Liu, W W.; Wu, Z.; , et al. Tree analysis of mass spectral urine profiles discriminates transitional cell carcinoma of the bladder from noncancer patient.Clin. Biochem. 2004, 37, 772–779. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Schaub, S.; Wilkis, J.; Weiler, T.; Sangster, K.; Rush, D.; Nickerson, P. Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry.Kidney Int. 2004, 65, 323–332. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sasaki, K.; Sato, K.; Akiyama, Y.; Yanagihara, K.; Masaaki, O.; Yamauchi, K. Peptidomics-based approach reveals the secretion of the 29-residue COOH-terminal fragment of the putative tumor suppressor protein DMBT1 from pancreatic adenocarcinoma cell lines.Cancer Res. 2002, 62, 4894–4898. [PUBMED], [INFOTRIEVE], [CSA]
- Rosty, C.; Christa, L.; Kuzdzal, S.; Baldwin, W M.; Zahurak, M L.; , et al. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology.Cancer Res. 2002, 62, 1868–1875. [PUBMED], [INFOTRIEVE], [CSA]
- von Eggeling, F.; Davies, H.; Lomas, L.; Fiedler, W.; Junker, K.; , et al. Tissue-specific microdissection coupled with Protein Chip array technologies: applications in cancer research.BioTechniques 2000, 29, 1066–1069. [PUBMED], [INFOTRIEVE], [CSA]
- Wu, W.; Tang, X.; Hu, W.; Lotan, R.; Hong, W K.; Mao, L. Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry.Clin. Exp. Metastasis 2002, 19, 319–326. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wadsworth, J T.; Somers, K D.; Stack, B C.J.; Cazares, L.; Malik, G.; , et al. Identification of patients with head and neck cancer using serum protein profiles.Arch. Otolaryngol. Head Neck Surg. 2004, 130, 98–104. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zhukov, T A.; Johanson, R A.; Cantor, A B.; Clark, R A.; Tockman, M S. Discovery of distinct protein profiles specific for lung tumors and premalignant lung lesions by SELDI mass spectrometry.Lung Cancer 2003, 40, 267–279. [PUBMED], [INFOTRIEVE], [CSA]
- Dolios, G.; Roboz, J.; Wang, R. In Identification of colon cancer associated protein in plasma using MALDI-TOF mass spectrometry, 51st ASMS Conf. Mass Spectrometry and Allied Topics, 2003.
- Ferrari, L.; Seraglia, R.; Rossi, C R.; Bertazzo, A.; Lise, M.; Allegri, G.; Traldi, P. Protein profiles in sera of patients with malignant cutaneous melanoma.Rapid Commun. Mass Spectrom. 2000, 14, 1149–1154. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Poon, T C.W.; Yip, T.; Chan, A T.C.; Yip, C.; Yip, V.; , et al. Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes.Clin. Chem. 2003, 49, 752–760. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zhu, X D.; Liang, W J.; Tien, P.; Zhang, W H.; Xu, Y.; Li, C L. New serum biomarkers for detection of HBV-induced liver cirrhosis using SELDI protein chip technology.World J. Gastroenterol. 2004, 10, 2327–2329. [PUBMED], [INFOTRIEVE], [CSA]
- Leak, L V.; Liotta, L A.; Krutzsch, H.; Jones, M.; Fusaroa, V A.; , et al. Proteomic analysis of lymph.Proteomics 2004, 4, 753–765. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Langlois, R G.; Trebes, J E.; Dalmasso, E A.; Ying, Y.; , et al. Serum protein profile alterations in hemodialysis patients.Am. J. Nephrol. 2004, 24, 268–274. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tolson, J.; Bogumil, R.; Brunst, E.; Beck, H.; Elsner, R.; , et al. Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients.Lan. Invest. 2004, 84, 845–856. [CSA], [CROSSREF]
- Hayman, M W.; Przyborski, S A. Proteomic identification of biomarkers expressed by human pluripotent stem cells.Biochem. Biophys. Res. Commun. 2004, 316, 918–923. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lin, Z.; Jenson, S D.; Lim, M S.; Elenitoba-Johnson, K S. Application of SELDI-TOF mass spectrometry for the identification of differentially expressed proteins in transformed follicular lymphoma.Mod. Pathol. 2004, 17, 670–678. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kern, C.; Cornuel, J F.; Billard, C.; Tang, R.; Rouillard, D.; , et al. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway.Blood 2004, 103, 679–688. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Shiwa, M.; Nishimura, Y.; Wakatabe, R.; Fukawa, A.; Arikuni, H.; , et al. Rapid discovery and identification of a tissue-specific tumor biomarker from 39 human cancer cell lines using the SELDI proteinchip platform.Biochem. Biophys. Res. Commun. 2003, 309, 18–25. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Nishizuka, S.; Charboneau, L.; Young, L.; Major, S.; Reinhold, W C.; , et al. Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays.Proc. Natl. Acad. Sci. U. S. A. 2003, 100, 14229–14234. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Fetsch, P A.; Simone, N L.; Bryand-Greenwood, P K.; Marincola, F M.; Filie, A C.; , et al. Proteomics evaluation of archival cytologic material using SELDI affinity mass spectrometry.Am. J. Clin. Pathol. 2002, 118, 870–876. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pritzker, K P. Cancer biomarkers: easier said than done.Clin. Chem. 2002, 48, 1147–1150. [PUBMED], [INFOTRIEVE], [CSA]
- Diamandis, E P. Proteomic patterns in serum and identification of ovarian cancer.Lancet 2002, 360, 170. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Diamandis, E P. Re: diagnostic potential of serum proteomic patterns in prostate cancer.J. Urol. 2004, 171, 1244–1245. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Diamandis, E P. Point: proteomic patterns in biological fluids: do they represent the future of cancer diagnostics?Clin. Chem. 2003, 49, 1272–1275. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Petricoin, E F.; Liotta, L A. Counterpoint: the vision for a new diagnostic paradigm.Clin. Chem. 2003, 49, 1276–1278. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Diamandis, E P. Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems.J. Natl. Cancer Inst. 2004, 96, 353–356. [PUBMED], [INFOTRIEVE], [CSA]
- Diamandis, E P. Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunties and potential limitations.Mol. Cell Proteomics 2004, 1–43. [CSA]
- Baggerly, K A.; Morris, J S.; Coombes, K R. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments.Bioinformatics 2004, 20, 777–785. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]